The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_000038.6(APC):c.532-8G>A

CA16611747

411469 (ClinVar)

Gene: APC
Condition: familial adenomatous polyposis 1
Inheritance Mode: Autosomal dominant inheritance
UUID: ce50ff0f-3705-41a6-81a6-1ad20b3b3a2b
Approved on: 2023-02-18
Published on: 2023-03-14

HGVS expressions

NM_000038.6:c.532-8G>A
NM_000038.6(APC):c.532-8G>A
NC_000005.10:g.112780782G>A
CM000667.2:g.112780782G>A
NC_000005.9:g.112116479G>A
CM000667.1:g.112116479G>A
NC_000005.8:g.112144378G>A
NG_008481.4:g.93262G>A
ENST00000257430.9:c.532-8G>A
ENST00000257430.8:c.532-8G>A
ENST00000507379.5:c.562-8G>A
ENST00000508376.6:c.532-8G>A
ENST00000508624.5:c.532-8G>A
ENST00000512211.6:c.532-8G>A
NM_000038.5:c.532-8G>A
NM_001127510.2:c.532-8G>A
NM_001127511.2:c.562-8G>A
NM_001354895.1:c.532-8G>A
NM_001354896.1:c.532-8G>A
NM_001354897.1:c.562-8G>A
NM_001354898.1:c.457-8G>A
NM_001354899.1:c.532-8G>A
NM_001354900.1:c.355-8G>A
NM_001354901.1:c.355-8G>A
NM_001354902.1:c.562-8G>A
NM_001354903.1:c.532-8G>A
NM_001354904.1:c.457-8G>A
NM_001354905.1:c.355-8G>A
NM_001354906.1:c.-504-8G>A
NM_001127510.3:c.532-8G>A
NM_001127511.3:c.562-8G>A
NM_001354895.2:c.532-8G>A
NM_001354896.2:c.532-8G>A
NM_001354897.2:c.562-8G>A
NM_001354898.2:c.457-8G>A
NM_001354899.2:c.532-8G>A
NM_001354900.2:c.355-8G>A
NM_001354901.2:c.355-8G>A
NM_001354902.2:c.562-8G>A
NM_001354903.2:c.532-8G>A
NM_001354904.2:c.457-8G>A
NM_001354905.2:c.355-8G>A
NM_001354906.2:c.-504-8G>A
More

Pathogenic

The Expert Panel has overridden the computationally generated classification - "Uncertain Significance - Insufficient Evidence"
Met criteria codes 4
PS4_Moderate PS3 PM2_Supporting PP3

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
InSiGHT Hereditary Colorectal Cancer/Polyposis VCEP
The c.532-8G>A variant in APC is an intronic variant which is located 8 nucleotides upstream of the splice acceptor site for exon 6. This variant has been reported in 3 families meeting phenotypic criteria, resulting in a total phenotype score of 2.5 (PS4_Moderate; Ambry internal data; Invitae internal data; Leiden, Bonn, PMID 24599579; PMID19196998). This variant is absent from gnomAD v2.1.1 (PM2_supporting). The results from ≥2 in silico splicing predictors (SpliceAI, MaxEntScan, VarSeak) indicate that this variant may affect splicing by disrupting the acceptor splice site of intron 5 of APC (PP3). RT-PCR and minigene assay demonstrate that this variant impacts splicing by creating a novel splice acceptor site six nucleotides upstream of the regular splice acceptor site of exon 6 which results in the inclusion of six nucleotides including a premature termination codon. A complete splice defect was confirmed using transcript-specific PCR and SNP analysis of c.1458T>C (PS3_VeryStrong; PMID 19196998). In summary, this variant meets the criteria to be classified as Pathogenic for FAP based on the ACMG/AMP criteria applied, as specified by the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel: PS3_VeryStrong; PS4_moderate; PM2_supporting; PP3 (VCEP specifications version 1; date of approval: 12/12/2022).
Met criteria codes
PS4_Moderate
This variant has been reported in 3 families meeting phenotypic criteria, resulting in a total phenotype score of 2.5 (PS4_Moderate; Ambry internal data; Invitae internal data; Leiden, Bonn, PMID 24599579; PMID19196998).
PS3
RT-PCR and minigene assay demonstrated that this variant impacts splicing by creating a novel splice acceptor site 6 nucleotides upstream of exon 6 which is included in the transcript and also encodes a premature termination codon. A complete splice defect was confirmed using transcript-specific PCR and SNP analysis of c.1458T/C (PMID 19196998) (PS3_VeryStrong).
PM2_Supporting
This variant is absent from gnomAD v2.1.1 (PM2_Supporting).
PP3
The results from ≥2 in silico splicing predictors (SpliceAI, MaxEntScan, VarSeak) indicate that this variant may affect splicing by disrupting the acceptor splice site of intron 5 of APC (PP3).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.